Bilateral Striatal Necrosis after Sydenham's Chorea in a 7-Year-Old Boy: A 2-Year Follow-Up by Canavese, C et al.
Bilateral Striatal Necrosis after Sydenham’s Chorea
in a 7-Year-Old Boy: A 2-Year Follow-Up
C. Canavese1 C. Davico1 M. Casabianca1 C. Olivieri2 S. Mancini1 G. Migliore2 A. Versace2
A. Tocchet1 B. Vitiello1
1Department of Pediatric Neurology, University of Turin, Children
Hospital Regina Margherita, Turin, Italy
2Department of Pediatric Emergency, Children Hospital Regina
Margherita, Turin, Italy
Neuropediatrics 2018;49:209–212.
Address for correspondence C. Davico, MD, Department of Pediatric
Neurology, University of Turin, Children Hospital Regina Margherita,
Piazza Polonia 94, 10100 Turin, Italy (e-mail: caiadav@fastwebnet.it).
Introduction
Bilateral striatal necrosis (BSN) is a rare condition patho-
logically characterized by insult to the neostriata (putamen
and caudate), ultimately leading to cellular necrosis.1,2 It
presents clinically with dystonic movements and is accompa-
nied by specific neuroimaging abnormalities.1 Permanent
neurological sequelae are common, even though full recovery
has been reported.2 The etiology of BSN is heterogeneous,
including viral and mycoplasma infections, mitochondrial
disorders, autoimmune encephalitis, genetic factors, hypogly-
cemia, and exposure to exogenous or endogenous toxins.1–3
Group A streptococcus (GAS) can be involved in various
neurological disorders caused by aberrant immune responses
to its antigens, with a consequent autoimmune disease. The
spectrum of post-GAS disease of the central nervous system
includes movement disorders (chorea, tics, dystonia, and
Parkinsonism), due to involvement of basal ganglia.
Previously, two cases of BSN consequent to GAS infection
were reported, one in a 14-month old infant and the other in
a 4-year-old child.4 In these cases, the clinical presentation
included dystonia, but not chorea.
Wehere describe a case of a 7-year-old boyfirst diagnosed
with Sydenham’s chorea (SC), who later progressively devel-
oped a generalized choreodystonic syndrome associated
with BSN.
Case Report
A 7-year-old boy presented to our hospital for worsening of
involuntarymovements of the limbs that had started 10 days
before, together with unstable walking and dysgraphia.
There were repetitive, chaotic, asynchronous involuntary
movements of the four limbs, tongue impersistence, and
dysgraphia (see ►Video 1). Past medical history was unre-
markable, except for recurrent pharyngitis.
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Abstract Child bilateral striatal necrosis (BSN) is a rare and etiologically heterogeneous condi-
tion. An association with group A streptococcus (GAS) infection was previously
reported in two cases of BSN in infancy and early childhood. We here report on a
7-year-old boy who developed chorea and dystonia 20 days after symptomatic recovery
from Sydenham’s chorea. Repeated brainmagnetic resonance imaging scans, obtained
before, soon after the onset of the post-Sydenham symptoms, and 1 year later were
consistent with an evolution from bilateral striatal microbleeding to necrosis, and
consequently reduced basal ganglia volume and enlargement of the frontal horns. No
support was found for other possible autoimmune, infectious, metabolic, toxic or
genetic etiologies for BSN. Prednisone treatment was instituted and continued for
1 year. Two years after the onset of the post-Sydenham symptoms, the child, although
much improved, still has generalized dystonic–choreic movements. This case confirms
and extends into school age, the link between GAS and BSN.
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Video 1
Repetitive, chaotic, asynchronous involuntary
movements of the four limbs, tongue impersistence,
and dysgraphia at onset. Online content including
video sequences viewable at: www.thieme-connect.
com/products/ejournals/html/10.1055/s-0037-
1618590.
A clinical diagnosis of SC was supported by laboratory
testing showing high antistreptolysin O titer (643 IU/mL) and
high level of antideoxyribonuclease antibody (1274 IU/mL).
Nasopharyngeal swabwas positive for GAS β-hemolytic. The
other laboratory tests (antinuclear antibodies, lupus antic-
oagulant, anticardiolipin antibodies, β2-glycoprotein I anti-
bodies) as well as cardiac echography were normal.
The boy was treated with oral prednisone 2 mg/kg/day, and
prophylaxis with benzathine penicillin was started. Due to the
extremely intense movement disorder, oral haloperidol 1 mg/
day was added and tapered off over 15 days. He progressively
improved and reached full symptomatic remission in 10 days.
At this time, brain magnetic resonance imaging (MRI)
showed bilateral T2 hyperintensity, without restricted diffu-
sion on diffusion-weighted images, and mild T1 hyperinten-
sity in the caudate nuclei and anterior portion of putamina
(►Fig. 1A, B). These images were interpreted as microbleed-
ing following vasculitis in rheumatic chorea.5
Metabolic investigations (lactate and pyruvate, ammonia,
amino acids, organic acid, acylcarnitine, carboxyhemoglo-
bin) and testing for thrombophiliawere normal. No evidence
was found for possible carbon monoxide poisoning.
After being in remission and completely asymptomatic for
20 days, neurological symptoms reappeared with different
features: choreic movements were associated with dystonia
and stiffness,mainly involving the legs (see►Video 1). A new
brain MRI was performed, showing a mild reduction in
previously described T2 hyperintensity and an increase in
T1 hyperintensity in the caudate nuclei and the anterior
portion of putamina (►Fig. 1C, D), suggesting an evolution
toward BSN. No Kayser–Fleischer rings were visible. Tests of
copper metabolism, thiamin, and antibodies to Mycoplasma
pneumoniae were normal.
Fig. 1 (A) First magnetic resonance imaging (MRI) (25 days after onset), axial T1-weighted image showing mild hyperintensity in caudate nuclei
and anterior portion of putamina. (B) First MRI, axial fluid-attenuated inversion recovery (FLAIR) image showing hyperintensity in caudate nuclei
and anterior portion of putamina. (C) Third MRI (1 month and 15 days after onset), axial T1-weighted image showing an increase in
hyperintensity in the caudate nuclei and anterior portion of putamina. (D) Fourth MRI, axial FLAIR showing hyperintensity in the caudate nuclei
and anterior portion of putamina. (E, F) Fifth MRI (3 months and a half after onset), axial FLAIR and T2-weighted images showing hyperintensity
in the caudate nuclei and anterior portion of putamina with reduced volume of basal nuclei and enlarged frontal horns. (G, H) Sixth MRI (2 years
after onset), axial T1-weighted image showing cavitation in caudate nuclei and anterior portion of putamina. (I) Seventh MRI, coronal flair image
showing hyperintensity in caudate nuclei and anterior portion of putamina.
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A brain computed tomography excluded cerebral calcifi-
cations. Cerebrospinal fluid (CSF) showed normal cell count,
glucose, lactate, amino acids, and proteins. CSF polymerase
chain reaction for group A streptococcus andM. pneumoniae
was negative. The CSF autoantibodies panel for autoimmune
encephalitis, including AMPA, GABA(b), mGluR1, mGluR5,
LGI1, Caspr2, NMDAR, andD2Rwere negative. Analysis of the
genetic panel for striatal bilateral necrosis was negative
for the following genes: ADAR, GCCDH, NUP62, SLC19A3,
SLC25A19, TPK1, TUBB4A. Antistreptolysin O antibodies titer
was 310 IU/mL and antideoxyribonuclease antibodies titer
was 620 IU/mL.
The patient was treatedwith intravenous immunoglobulin
(in consideration of a postulated postinfectious GAS autoim-
munemechanism), but with negligible response. Hewas then
given pulse intravenous methylprednisolone, starting with
30 mg/kg/day, gradually reduced in the following days, with
a considerable improvement, but not complete regression, in
the involuntarymovements (see►Video 1). Oral methylpred-
nisolone was then substituted for prednisone and this treat-
ment was continued for about 1 year. Additional treatment
included therapy with tetrabenazine, oral supplementation of
thiamine and biotin, and physical rehabilitation.
Brain MRI performed 2 months later showed vanishing of
T1 hyperintensity (previously described in the caudate
nuclei and the anterior portion of putamina) but T2 hyper-
intensity in the same areas persisted unmodified (►Fig. 1
E, F); the volume of basal nuclei was reduced and the frontal
horns were enlarged. These images confirmed a stabilization
of the necrotic process.
Currently, 2 years after the onset, the child is in a stable
clinical condition, with a persistent, although attenuated,
generalized dystonic–choreic syndrome. There has been no
cognitive and behavioral deterioration. He receives ongoing
thiamine, biotin, and benzathine penicillin prophylaxis. Tri-
hexifenidilo was briefly tried, but caused blurred vision and
no significant benefit. The latest brain MRI, 2 years after
onset, confirmed the reduction in basal nuclei volume with
signs of cavitation (►Fig. 1 G–I).
Discussion
To our knowledge, this is the first report of a case of BSN in a
school-age child that can be etiologically linked to GAS
infection. After developing SC, this patient clinically recov-
ered and was asymptomatic for 20 days before presenting
with generalized dystonic–choreic movements and brain
imaging evidence of BSN.
SC is considered the prototype autoimmune disease
of central nervous system triggered by a streptococcal
infection.5–10
BSN following streptococcal infection is a very rare com-
plication and only two cases had been previously reported.4
These patients were very young (14-month and 4-year old,
respectively), and both presented with dystonia, but not
chorea. It can be speculated that the age when the immuno-
logical basal ganglia insult occurs may influence the resulting
clinical manifestation. For example, an infantile or early child-
hood insult may result in a dystonic outcome, whereas a later
childhood disease may result in chorea.
In post-GAS disorders affecting central nervous system,
brain MRI is usually normal, except for unspecific inflam-
matory changes in the basal ganglia.11 In post-GAS or a
specific postinfectious extrapyramidal movement disorder,
basal ganglia can showMRI signs consistent with inflamma-
tion and seldom necrosis.12,13
In BNS, brain MRI shows initial T2 and fluid-attenuated
inversion recovery (FLAIR) hyperintensity of swollen neo-
striata anda subsequenthypointensityonT1-weighted images
due to progressive atrophy.14
When our patient first developed SC, brain MRI showed
bilateral T2 hyperintensity of basal ganglia, which were
interpreted as consequence of microbleeding due to vascu-
litis in rheumatic chorea. These lesions progressively evolved
into necrosis, as evidenced by MRI signs of atrophy.
Extensive and repeated testing ruled out alternative
explanations, including other infections, metabolic, toxic,
or genetic causes. The possibility of an autoimmune ence-
phalitis was considered, but ruled out by negative CSF anti-
NMDAR and D2 antibodies tests.
A considerable reduction in choreoathetotic movements
and dystonia was achieved on intravenous steroids therapy,
thus supporting an inflammatory/autoimmune genesis of the
pathological process. The symptomatic course was consistent
with the pathological process: the initial classic choreicmove-
ments eventually abated, but to be then followed, after a
20-day asymptomatic period, by more complex dystonic pos-
tures andmovements. Twoyears later, thoughmuch improved,
he still presents with dystonia, which can be now considered
stable and permanent. It is noteworthy that there are no other
neurological or cognitive deficits. Thus, the clinical, laboratory,
brain imaging, and treatment data are all consistent with a
diagnosis of post-GAS BSN.
Conclusion
This case shows that BSNcanoccurconsequent toSC in school-
age children, and provides further evidence that GAS infection
can, in rare cases, trigger a cascade of events resulting in
permanent basal ganglia damage and neurological sequelae.
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